Mosaic Immunoengineering Net Income
| CPMV Stock | USD 0.53 0.22 70.97% |
As of the 16th of February 2026, Mosaic Immunoengineerin secures the Downside Deviation of 19.5, mean deviation of 10.0, and Risk Adjusted Performance of 0.0475. Mosaic Immunoengineering technical analysis lets you operate historical price patterns with an objective to determine a pattern that forecasts the direction of the firm's future prices. Strictly speaking, you can use this information to find out if the firm will indeed mirror its model of past prices, or the prices will eventually revert. We have collected data for nineteen technical drivers for Mosaic Immunoengineerin, which can be compared to its peers in the industry. Please verify Mosaic Immunoengineering variance and potential upside to decide if Mosaic Immunoengineering is priced some-what accurately, providing market reflects its recent price of 0.53 per share. As Mosaic Immunoengineering is a penny stock we also strongly advise to check its total risk alpha numbers.
Mosaic Immunoengineerin's financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Mosaic Immunoengineerin's valuation are provided below:Mosaic Immunoengineering does not presently have any fundamental ratios for analysis. This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools. Mosaic |
Mosaic Immunoengineerin 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Mosaic Immunoengineerin's otc stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Mosaic Immunoengineerin.
| 11/18/2025 |
| 02/16/2026 |
If you would invest 0.00 in Mosaic Immunoengineerin on November 18, 2025 and sell it all today you would earn a total of 0.00 from holding Mosaic Immunoengineering or generate 0.0% return on investment in Mosaic Immunoengineerin over 90 days. Mosaic ImmunoEngineering Inc., a development-stage biotechnology company, focuses on developing and commercializing immu... More
Mosaic Immunoengineerin Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Mosaic Immunoengineerin's otc stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Mosaic Immunoengineering upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 19.5 | |||
| Information Ratio | 0.0433 | |||
| Maximum Drawdown | 128.48 | |||
| Value At Risk | (22.00) | |||
| Potential Upside | 40.0 |
Mosaic Immunoengineerin Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Mosaic Immunoengineerin's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Mosaic Immunoengineerin's standard deviation. In reality, there are many statistical measures that can use Mosaic Immunoengineerin historical prices to predict the future Mosaic Immunoengineerin's volatility.| Risk Adjusted Performance | 0.0475 | |||
| Jensen Alpha | 0.8193 | |||
| Total Risk Alpha | (0.53) | |||
| Sortino Ratio | 0.0426 | |||
| Treynor Ratio | 0.7398 |
Mosaic Immunoengineerin February 16, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.0475 | |||
| Market Risk Adjusted Performance | 0.7498 | |||
| Mean Deviation | 10.0 | |||
| Semi Deviation | 11.22 | |||
| Downside Deviation | 19.5 | |||
| Coefficient Of Variation | 2128.13 | |||
| Standard Deviation | 19.19 | |||
| Variance | 368.12 | |||
| Information Ratio | 0.0433 | |||
| Jensen Alpha | 0.8193 | |||
| Total Risk Alpha | (0.53) | |||
| Sortino Ratio | 0.0426 | |||
| Treynor Ratio | 0.7398 | |||
| Maximum Drawdown | 128.48 | |||
| Value At Risk | (22.00) | |||
| Potential Upside | 40.0 | |||
| Downside Variance | 380.37 | |||
| Semi Variance | 125.87 | |||
| Expected Short fall | (30.91) | |||
| Skewness | 1.63 | |||
| Kurtosis | 6.19 |
Mosaic Immunoengineering Backtested Returns
Mosaic Immunoengineerin is out of control given 3 months investment horizon. Mosaic Immunoengineering has Sharpe Ratio of 0.076, which conveys that the firm had a 0.076 % return per unit of risk over the last 3 months. We have collected data for twenty-seven different technical indicators, which can help you to evaluate if expected returns of 1.48% are justified by taking the suggested risk. Use Mosaic Immunoengineering Downside Deviation of 19.5, mean deviation of 10.0, and Risk Adjusted Performance of 0.0475 to evaluate company specific risk that cannot be diversified away. Mosaic Immunoengineerin holds a performance score of 6 on a scale of zero to a hundred. The company secures a Beta (Market Risk) of 1.21, which conveys a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Mosaic Immunoengineerin will likely underperform. Use Mosaic Immunoengineering jensen alpha, potential upside, as well as the relationship between the Potential Upside and daily balance of power , to analyze future returns on Mosaic Immunoengineering.
Auto-correlation | 0.05 |
Virtually no predictability
Mosaic Immunoengineering has virtually no predictability. Overlapping area represents the amount of predictability between Mosaic Immunoengineerin time series from 18th of November 2025 to 2nd of January 2026 and 2nd of January 2026 to 16th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Mosaic Immunoengineering price movement. The serial correlation of 0.05 indicates that only as little as 5.0% of current Mosaic Immunoengineerin price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.05 | |
| Spearman Rank Test | 0.07 | |
| Residual Average | 0.0 | |
| Price Variance | 0.01 |
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
| Competition |
Based on the recorded statements, Mosaic Immunoengineering reported net income of (3.68 Million). This is 101.08% lower than that of the Healthcare sector and 105.26% lower than that of the Biotechnology industry. The net income for all United States stocks is 100.65% higher than that of the company.
Mosaic Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Mosaic Immunoengineerin's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the otc stocks which would be a good addition to a portfolio. Peer analysis of Mosaic Immunoengineerin could also be used in its relative valuation, which is a method of valuing Mosaic Immunoengineerin by comparing valuation metrics of similar companies.Mosaic Immunoengineerin is currently under evaluation in net income category among its peers.
Mosaic Fundamentals
| Return On Asset | -4.2 | |||
| Current Valuation | 10.22 M | |||
| Shares Outstanding | 7.24 M | |||
| Shares Owned By Insiders | 88.73 % | |||
| Price To Book | 9.33 X | |||
| EBITDA | (3.52 M) | |||
| Net Income | (3.68 M) | |||
| Cash And Equivalents | 205.99 K | |||
| Cash Per Share | 0.03 X | |||
| Total Debt | 735.15 K | |||
| Current Ratio | 0.07 X | |||
| Book Value Per Share | (0.60) X | |||
| Cash Flow From Operations | (679.24 K) | |||
| Earnings Per Share | (0.51) X | |||
| Beta | -1.79 | |||
| Market Capitalization | 6.01 M | |||
| Total Asset | 269.49 K | |||
| Z Score | -38.1 | |||
| Net Asset | 269.49 K |
About Mosaic Immunoengineerin Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Mosaic Immunoengineering's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Mosaic Immunoengineerin using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Mosaic Immunoengineering based on its fundamental data. In general, a quantitative approach, as applied to this otc stock, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Mosaic OTC Stock Analysis
When running Mosaic Immunoengineerin's price analysis, check to measure Mosaic Immunoengineerin's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Mosaic Immunoengineerin is operating at the current time. Most of Mosaic Immunoengineerin's value examination focuses on studying past and present price action to predict the probability of Mosaic Immunoengineerin's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Mosaic Immunoengineerin's price. Additionally, you may evaluate how the addition of Mosaic Immunoengineerin to your portfolios can decrease your overall portfolio volatility.